In a 32-year-old male with multiple mosquito bites on the thighs that progressed over 20 days to a generalized pruritic papular eruption, now presenting with blurred vision and mild conjunctival redness but no fever or systemic symptoms, what is the most likely diagnosis, appropriate treatment with dosages, and differential diagnoses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Diagnosis: Severe Mosquito Bite Allergy (SMBA) with Possible EBV-Associated NK-Cell Lymphoproliferative Disorder

The most likely diagnosis is severe mosquito bite allergy (SMBA) with systemic progression, requiring immediate workup for EBV-associated NK-cell lymphoproliferative disorder and urgent ophthalmologic evaluation for potential uveitis or EBV-related ocular complications. 1

Clinical Reasoning

This 32-year-old male presents with a classic progression pattern concerning for SMBA:

  • Initial localized mosquito bites on thighs
  • Progressive generalized pruritic papular eruption over 20 days
  • New-onset blurred vision with conjunctival injection (mild scleral redness)
  • Absence of fever or systemic pain

The temporal progression from localized to generalized reaction over weeks, combined with ocular involvement, distinguishes this from simple papular urticaria and raises concern for SMBA, which is classified within EBV-positive T/NK-cell lymphoproliferative disorders 1. The ocular findings are particularly concerning as EBV-associated disorders can cause uveitis, choroiditis, and retinal complications 2.

Immediate Diagnostic Workup Required

Critical tests to order immediately:

  • EBV DNA quantitative PCR (peripheral blood) - essential for SMBA diagnosis 1
  • Complete blood count with differential - assess for lymphoproliferative disorder
  • Skin biopsy from papular lesion - look for angiocentric infiltration of EBV-positive NK cells 1
  • Comprehensive ophthalmologic examination - assess for uveitis, retinitis, or other EBV-related complications 2
  • Specific IgE testing to mosquito salivary antigens if available 3

Treatment Protocol

Immediate Management (Start Today):

Primary regimen:

  • Oral prednisone 40-60 mg daily (0.5-1 mg/kg) for severe SMBA 1
  • Cetirizine 20 mg once daily (double standard dose for mosquito allergy) 4, 5
  • Valacyclovir 1000 mg daily (for potential EBV reactivation) 5

Adjunctive therapy:

  • Topical clobetasone butyrate 0.05% to papular lesions twice daily 6
  • Cold compresses and refrigerated preservative-free artificial tears for ocular symptoms 2
  • Emollients liberally to all affected areas 6

Steroid-Sparing Alternative (if prolonged treatment needed):

If the patient requires extended management or has contraindications to prolonged corticosteroids, consider the steroid-sparing regimen that has shown success in similar cases 5:

  • Doxycycline 100 mg twice daily
  • Cetirizine 20 mg once daily
  • Valacyclovir 1000 mg daily

This combination resulted in sustained reduction in bullous eruptions in a documented case of MCL-associated exaggerated mosquito bite reactions 5.

Differential Diagnoses (In Order of Likelihood)

  1. Severe Mosquito Bite Allergy (SMBA) with EBV-associated NK-cell LPD - Most likely given progressive generalized reaction and ocular involvement 1

  2. Papular Urticaria - Common in adults following mosquito bites, but typically doesn't progress to generalized distribution or cause ocular symptoms 7, 8

  3. Skeeter Syndrome - Large local inflammatory reactions to mosquito bites with systemic symptoms, but usually more acute onset 3

  4. Wells' Syndrome (Eosinophilic Cellulitis) - Can present with exaggerated mosquito bite reactions and robust CD4+ T cell proliferation, but typically lacks ocular involvement 9

  5. Acute Generalized Exanthematous Pustulosis (AGEP) - Rare trigger by mosquito bites, but presents with sterile pustules rather than papules 10

  6. Viral Conjunctivitis (Zika, EBV, or other arbovirus) - Mosquito-borne transmission possible, but wouldn't explain the progressive generalized papular eruption pattern 2

  7. Systemic Lupus Erythematosus flare - Mosquito bites can trigger SLE flares with targetoid rash, but patient lacks other SLE features 11

  8. Underlying Hematologic Malignancy (MCL or other B-cell neoplasm) - Can present with exaggerated mosquito bite reactions 9, 5

Critical Pitfalls to Avoid

Do not dismiss the ocular symptoms - The combination of progressive generalized reaction with ocular involvement suggests systemic disease beyond simple hypersensitivity. EBV-associated disorders can cause sight-threatening complications including retinitis, choroiditis, and optic neuritis 2.

Do not use topical corticosteroids on the eyes without ophthalmology consultation - Corticosteroids can worsen certain viral infections and should only be used under specialist guidance for ocular symptoms 2.

Do not delay EBV testing - SMBA is recognized as a specific cutaneous manifestation of chronic active EBV disease with potential progression to overt T/NK-cell leukemia or lymphoma 1. Early detection is critical.

Avoid indiscriminate antibiotic use - Unless secondary bacterial infection is evident, antibiotics are not indicated for mosquito bite reactions 2.

Follow-Up Protocol

  • Ophthalmology referral within 24-48 hours for comprehensive eye examination
  • Hematology referral if EBV DNA load is elevated or CBC shows abnormalities
  • Reassess in 3-5 days to evaluate treatment response
  • Monitor for progression to necrotic ulcers, bullae, or systemic symptoms (fever, lymphadenopathy) which would indicate more aggressive disease 1
  • Long-term surveillance if EBV-positive, as these patients require monitoring for progression to lymphoma 1

The elderly-onset case reported in 2026 demonstrated that even with high EBV loads, patients can maintain stable, indolent courses with appropriate treatment 1, making early diagnosis and management crucial for optimal outcomes.

Related Questions

What reassurance and management should I provide for a patient with a transient reddish‑blue spot after a mosquito bite—no pseudoaneurysm or hematoma—and how should I address the unexpected ER bill?
What could be causing my symptoms of diarrhea, stomach sickness, soreness, fever, and itchy red blotches from bug bites, which my relative has also developed after I did, following a recent trip?
What is the appropriate management for a 62-year-old woman with persistent insect-bite–type lesions on her legs and arms that are red, raised, itchy, and appear as spaced-out spots?
What is the best course of treatment for a patient with no known history of allergies or atopic conditions, experiencing chronic swelling, redness, and itchiness after a mosquito bite, lasting over 2 months?
I think a mosquito bit me on my leg yesterday; could that bite be responsible for the leg tightness I experience when I stand after sitting for a long time?
What diagnostic tests are recommended to confirm mucormycosis?
In a patient with subacute appendicitis and normal C‑reactive protein, complete blood count, and erythrocyte sedimentation rate, should I change from intravenous piperacillin‑tazobactam after three days to oral amoxicillin‑clavulanate?
Which measurements are needed to size compression stockings—should I measure blood pressure or the lower‑extremity circumference?
What is the role of methylmalonic acid (MMA) in patients with persistent vitamin B12 deficiency despite supplementation?
My thyroid-stimulating hormone (TSH) is 5.66 mIU/L while I am taking levothyroxine 50 µg daily; should I increase the levothyroxine dose?
What medications and their dosages are recommended during advanced cardiopulmonary resuscitation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.